Fig. 4From: In vivo efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of CongoKaplan–Meier survival estimates PCR-unadjusted. Treatment efficacy for ASAQ and AL was 85.3 and 92.1 % at day 28 (p = 0.0933), and 77.7 and 84.5 % at day 42 (p = 0.1605), respectivelyBack to article page